APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis

Journal of Leukocyte Biology

Volumn 84, Issue 2, 2008, Pages 380-388

  Hardenberg, Gijs ^a   Fernandez, Leticia ^b   Hendriks, Jenny ^a   Chebli, Karim ^b   Jacquet, Chantal ^b   Sitbon, Marc ^b   Hahne, Michel ^b   Medema, Jan Paul ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Friend murine leukemia virus; Moloney murine leukemia virus; T lymphocyte; TACI

Indexed keywords

APRIL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELLULAR IMMUNITY; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA; EXPERIMENTAL MOUSE; HEMATOCRIT; IN VIVO STUDY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLENOMEGALY; T CELL LYMPHOMA; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; FLOW CYTOMETRY; HEMATOCRIT; HETEROZYGOTE; HOMOZYGOTE; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYMPHOMA, T-CELL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLONEY MURINE LEUKEMIA VIRUS; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; STEM CELLS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; MUS;

EID: 48649089330     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1207853     Document Type: Article

References (42)

1. Hahne, M., Kataoka, T., Schroter, M., Hofmann, K., Irmler, M., Bodmer, J. L., Schneider, P., Bornand, T., Holler, N., French, L. E., Sordat, B., Rimoldi, D., Tschopp, J. (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188, 1185-1190.
2. Hardenberg, G., Planelles, L., Schwarte, C. M., van Bostelen, L., Le Huong, T., Hahne, M., Medema, J. P. (2007) Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner. Eur. J. Immunol. 37, 2900-2911.
3. Nardelli, B., Belvedere, O., Roschke, V., Moore, P. A., Olsen, H. S., Migone, T. S., Sosnovtseva, S., Carrell, J. A., Feng, P., Giri, J. G., Hilbert, D. M. (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97, 198-204.
4. Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. L., Aggarwal, B. B. (1999) Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274, 15978-15981.
5. Rennert, P., Schneider, P., Cachero, T. G., Thompson, J., Trabach, L., Hertig, S., Holler, N., Qian, F., Mullen, C., Strauch, K., Browning, J. L., Ambrose, C., Tschopp, J. (2000) A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 192, 1677-1684.
6. Hendriks, J., Planelles, L., de Jong-Odding, J., Hardenberg, G., Pals, S. T., Hahne, M., Spaargaren, M., Medema, J. P. (2005) Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12, 637-648.
7. Ingold, K., Zumsteg, A., Tardivel, A., Huard, B., Steiner, Q. G., Cachero, T. G., Qiang, F., Gorelik, L., Kalled, S. L., Acha-Orbea, H., Rennert, P. D., Tschopp, J., Schneider, P. (2005) Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201, 1375-1383.
8. Ng, L. G., Sutherland, A. P., Newton, R., Qian, F., Cachero, T. G., Scott, M. L., Thompson, J. S., Wheway, J., Chtanova, T., Groom, J., Sutton, I. J., Xin, C., Tangye, S. G., Kalled, S. L., Mackay, F., Mackay, C. R. (2004) B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173, 807-817.
9. O'Connor, B. P., Raman, V. S., Erickson, L. D., Cook, W. J., Weaver, L. K., Ahonen, C., Lin, L. L., Mantchev, G. T., Bram, R. J., Noelle, R. J. (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199, 91-98.
10. Treml, L. S., Carlesso, G., Hoek, K. L., Stadanlick, J. E., Kambayashi, T., Bram, R. J., Cancro, M. P., Khan, W. N. (2007) TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J. Immunol. 178, 7531-7539.
11. Seyler, T. M., Park, Y. W., Takemura, S., Bram, R. J., Kurtin, P. J., Goronzy, J. J., Weyand, C. M. (2005) BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 115, 3083-3092.
12. Von Bulow, G. U., Bram, R. J. (1997) NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278, 138-141.
13. Wu, Y., Bressette, D., Carrell, J. A., Kaufman, T., Feng, P., Taylor, K., Gan, Y., Cho, Y. H., Garcia, A. D., Gollatz, E., Dimke, D., LaFleur, D., Migone, T. S., Nardelli, B., Wei, P., Ruben, S. M., Ullrich, S. J., Olsen, H. S., Kanakaraj, P., Moore, P. A., Baker, K. P. (2000) Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275, 35478-35485.
14. Huard, B., Schneider, P., Mauri, D., Tschopp, J., French, L. E. (2001) T cell costimulation by the TNF ligand BAFF. J. Immunol. 167, 6225-6231.
15. Huard, B., Arlettaz, L., Ambrose, C., Kindler, V., Mauri, D., Roosnek, E., Tschopp, J., Schneider, P., French, L. E. (2004) BAFF production by antigen-presenting cells provides T cell co-stimulation. Int. Immunol. 16, 467-475.
16. Wang, H., Marsters, S. A., Baker, T., Chan, B., Lee, W. P., Fu, L., Tumas, D., Yan, M., Dixit, V. M., Ashkenazi, A., Grewal, I. S. (2001) TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2, 632-637.
17. Yu, G., Boone, T., Delaney, J., Hawkins, N., Kelley, M., Ramakrishnan, M., McCabe, S., Qiu, W. R., Kornuc, M., Xia, X. Z., Guo, J., Stolina, M., Boyle, W. J., Sarosi, I., Hsu, H., Senaldi, G., Theill, L. E. (2000) APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1, 252-256.
18. Siegel, R. M., Lenardo, M. J. (2001) To B or not to B: TNF family signaling in lymphocytes. Nat. Immunol. 2, 577-578.
19. Stein, J. V., Lopez-Fraga, M., Elustondo, F. A., Carvalho-Pinto, C. E., Rodriguez, D., Gomez-Caro, R., De Jong, J., Martinez, A. C., Medema, J. P., Hahne, M. (2002) APRIL modulates B and T cell immunity. J. Clin. Invest. 109, 1587-1598.
20. Varfolomeev, E., Kischkel, F., Martin, F., Seshasayee, D., Wang, H., Lawrence, D., Olsson, C., Tom, L., Erickson, S., French, D., Schow, P., Grewal, I. S., Ashkenazi, A. (2004) APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 24, 997-1006.
21. Castigli, E., Scott, S., Dedeoglu, F., Bryce, P., Jabara, H., Bhan, A. K., Mizoguchi, E., Geha, R. S. (2004) Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA 101, 3903-3908.
22. Planelles, L., Carvalho-Pinto, C. E., Hardenberg, G., Smaniotto, S., Savino, W., Gomez-Caro, R., Alvarez-Mon, M., de Jong, J., Eldering, E., Martinez, A. C., Medema, J. P., Hahne, M. (2004) APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 6, 399-408.
23. Novak, A. J., Bram, R. J., Kay, N. E., Jelinek, D. F. (2002) Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100, 2973-2979.
24. Kern, C., Cornuel, J. F., Billard, C., Tang, R., Rouillard, D., Stenou, V., Defrance, T., Ajchenbaum-Cymbalista, F., Simonin, P. Y., Feldblum, S., Kolb, J. P. (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103, 679-688.
25. Nishio, M., Endo, T., Tsukada, N., Ohata, J., Kitada, S., Reed, J. C., Zvaifler, N. J., Kipps, T. J. (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1. Blood 106, 1012-1020.
26. Novak, A. J., Grote, D. M., Stenson, M., Ziesmer, S. C., Witzig, T. E., Habermann, T. M., Harder, B., Ristow, K. M., Bram, R. J., Jelinek, D. F., Gross, J. A., Ansell, S. M. (2004) Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 104, 2247-2253.
27. He, B., Chadburn, A., Jou, E., Schattner, E. J., Knowles, D. M., Cerutti, A. (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172, 3268-3279.
28. Moreaux, J., Cremer, F. W., Reme, T., Raab, M., Mahtouk, K., Kaukel, P., Pantesco, V., De Vos, J., Jourdan, E., Jauch, A., Legouffe, E., Moos, M., Fiol, G., Goldschmidt, H., Rossi, J. F., Hose, D., Klein, B. (2005) The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106, 1021-1030.
29. Novak, A. J., Darce, J. R., Arendt, B. K., Harder, B., Henderson, K., Kindsvogel, W., Gross, J. A., Greipp, P. R., Jelinek, D. F. (2004) Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 103, 689-694.
30. Moreaux, J., Legouffe, E., Jourdan, E., Quittet, P., Reme, T., Lugagne, C., Moine, P., Rossi, J. F., Klein, B., Tarte, K. (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103, 3148-3157.
31. Dillon, S. R., Gross, J. A., Ansell, S. M., Novak, A. J. (2006) An APRIL to remember: novel TNF ligands as therapeutic targets. Nat. Rev. Drug Discov. 5, 235-246.
32. Chesebro, B., Portis, J. L., Wehrly, K., Nishio, J. (1983) Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus. Virology 128, 221-233.
33. Kina, T., Ikuta, K., Takayama, E., Wada, K., Majumdar, A. S., Weissman, I. L., Katsura, Y. (2000) The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol. 109, 280-287.
34. van Stipdonk, M. J., Hardenberg, G., Bijker, M. S., Lemmens, E. E., Droin, N. M., Green, D. R., Schoenberger, S. P. (2003) Dynamic programming of CD8 T lymphocyte responses. Nat. Immunol. 4, 361-365.
35. Audit, M., Dejardin, J., Hohl, B., Sidobre, C., Hope, T. J., Mougel, M., Sitbon, M. (1999) Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties. J. Virol. 73, 10472-10479.
36. Sitbon, M., Evans, L., Nishio, J., Wehrly, K., Chesebro, B. (1986) Analysis of two strains of Friend murine leukemia viruses differing in ability to induce early splenomegaly: lack of relationship with generation of recombinant mink cell focus-forming viruses. J. Virol. 57, 389-393.
37. Wikstrom, M. E., Batanero, E., Smith, M., Thomas, J. A., von Garnier, C., Holt, P. G., Stumbles, P. A. (2006) Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen. J. Immunol. 177, 913-924.
38. Deshayes, F., Lapree, G., Portier, A., Richard, Y., Pencalet, P., Mahieu-Caputo, D., Horellou, P., Tsapis, A. (2004) Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23, 3005-3012.
39. Planelles, L., Castillo-Gutierrez, S., Medema, J. P., Morales-Luque, A., Merle-Beral, H., Hahne, M. (2007) APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica 92, 1284-1285.
40. Fan, H. (1997) Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. 5, 74-82.
41. Gisselbrecht, S., Pozo, F., Debre, P., Hurot, M. A., Lacombe, M. J., Levy, J. P. (1978) Genetic control of sensitivity to Moloney-virus-induced leukemias in mice. I. Demonstration of multigenic control. Int. J. Cancer 21, 626-634.
42. Sitbon, M., Sola, B., Evans, L., Nishio, J., Hayes, S. F., Nathanson, K., Garon, C. F., Chesebro, B. (1986) Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell 47, 851-859.